Could AI signal the end of the use of lab rats in research? Olden Labs reveals all
A significant milestone has been reached by Olden Labs as it steps into the limelight revealing its refreshing approach to animal research.
Archives for April 29, 2024
Interview: Is global AI regulation really revolutionizing pharma and clinical trials?
OSP spoke to Berkeley Research Group healthcare managing director, Wendy Cheng for a discussion around developments in AI regulation for pharmaceuticals, clinical trials, and drug development at a global scale.
Has Response Pharmacauticals won the fight against antipsychotic weight gain?
Response Pharmaceuticals, Inc., has unveiled significant findings from its Phase 1b clinical trial of RDX-002, signaling a potential breakthrough in combatting antipsychotic-induced weight gain (AIWG).